Over the past decade, fluid biomarkers have transformed the conceptual and clinical framework of neurodegenerative diseases. In Alzheimer’s disease (AD), ...
Every decision in drug development carries weight. The right biomarker insights can make those decisions more confident and data-driven. In this white paper, experts from AstraZeneca, Johnson & ...
Medicaid Expansion and Stage at Diagnosis, Timely Initiation and Receipt of Guideline-Concordant Treatment, and Survival Among People With Non–Small Cell Lung Cancer The CHAI platform extracted ...
Tuberculosis (TB) remains one of the world's most serious public health threats, with approximately one-quarter of the global ...
Bridging Discovery with Clinical Practice: Biomarkers for Early Detection in Diabetic Kidney Disease
Diabetic kidney disease (DKD) is a major microvascular complication of diabetes and remains the leading cause of end-stage renal disease (ESRD) worldwide.
We’re in the midst of a paradigm shift in biomarker science. Once considered exploratory, biomarker signatures have evolved into strategic assets - tools that actively de-risk decision-making across ...
Please provide your email address to receive an email when new articles are posted on . ADx NeuroSciences and Alamar Biosciences have announced a partnership to develop customized biomarker assays for ...
Aging is a highly individual process. An international consortium coordinated by researchers in Konstanz has developed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results